The Safety, Tolerability and Immunogenicity of COVID-19 Vaccine (SCTV01C) in Healthy, Unvaccinated Adults
Clinical trial NCT05148091 · COMPLETED
Trial details
- NCT number
- NCT05148091
- Sponsor
- Sinocelltech Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2023-08-04
- Enrollment
- 478
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.